Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Crystal Pharmatech

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 1
Average round size
info
The average size of a deal this fund participated in
$15M
Portfolio companies 1
Rounds per year 0.09
Lead investments 0
Key employees Soon

Areas of investment

  • Pharmaceutical
  • Outsourcing
  • Biotechnology
  • Health Care
Summary

In 2010 was created Crystal Pharmatech, which is appeared as Corporate Investor. The fund was located in Asia if to be more exact in China. The leading representative office of defined Corporate Investor is situated in the Suzhou.

We can highlight the next thriving fund investment areas, such as Outsourcing, Pharmaceutical. For fund there is a match between the location of its establishment and the land of its numerous investments - China. Among the various public portfolio startups of the fund, we may underline Laviana Pharma Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund.

The standard case for the fund is to invest in rounds with 4 partakers. Despite the Crystal Pharmatech, startups are often financed by Lotus Lake Ventures, Agricultural Fund of China. The meaningful sponsors for the fund in investment in the same round are LYFE Capital, HY Capital, ABC Capital.

The fund is generally included in less than 2 deals every year. The important activity for fund was in 2018. The usual things for fund are deals in the range of 10 - 50 millions dollars.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
14th Street Global Ventures -
Bitfinex Taipei, Taiwan
CGF Capital Management Chaoyang, China, Liaoning
EE Capital Central, Central Region, Singapore
Front Row Ventures Canada, Montréal, Quebec
GC -
Insurance Australia Group (IAG) Australia, New South Wales, Sydney
Las Olas Venture Capital (LOVC) Florida, Fort Lauderdale, United States
Matignon Investissement & Gestion France, Ile-de-France, Paris
Maya Partner Ltd. -
Mitsubishi UFJ Financial Group Chiyoda, Japan
Princeton Alumni Angels -
RWI Group California, Palo Alto, United States
Serendipity Partners Norway, Oslo
Shanghai Fanzhong China, Jiading District
Shenzhen Yijia Jiankang China, Futian, Guangdong
Tabcorp Holdings Limited Australia, Melbourne, Victoria

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Laviana Pharma

Biotechnology
Health Care
Outsourcing
Pharmaceutical
$15M02 Jan 2018 Beijing

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Crystal Pharmatech?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 1
Average round size 15M
Rounds per year 0.09
Peak activity year 2018
Lead investments 0
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Laviana Pharma

Biotechnology
Health Care
Outsourcing
Pharmaceutical
$15M02 Jan 2018 Beijing
Crunchbase icon

Content report

The following text will be sent to our editors: